VGR-R01

N/A

Report date: 2024/11/25 20:00:28

Base Information

Drug NameVGR-R01
Drug Alias NameVGR-R01VGR-R-01
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV8 vector
Mechanisms of ActionCYP4V2 gene transference
TargetsCytochrome P450 4V2
Therapy Area/IndicationsBietti Crystalline DystrophyRetinal DiseasesRetinal Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Vitalgen BioPharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Tongren Hospital, CmuShanghai Vitalgen BioPharma Co Ltd
Inactive CompaniesN/A
Active IndicationsBietti Crystalline DystrophyRetinal DiseasesRetinal Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A